Details
About Us
Vial is a hyper-scalable biotech company advancing programs into the clinic by leveraging dramatically cheaper trials and computationally designed therapeutics.
Our mission is to reimagine drug development in order to cure all human diseases. We have assembled a talented team of clinical operators, chemists, and innovative thinkers to achieve this vision.
Vial is based in San Francisco, California, and was founded by Simon Burns in October 2020. Since our founding, we have grown rapidly to a team of 100+ employees with over $100 million in funding from leading investors including General Catalyst, Box Group, and Byers Capital.
Vial is rebuilding the infrastructure to advance research. By deploying technology at every step, we are creating a more efficient future for drug discovery.